Topics Overview | chemanager-online.com - Chemistry and Life Science

Sep. 23, 2018
TopicsProductionPharma & Biotech Processing
Opposites Attract
The biopharmaceutical industry has grown impressively in recent years, with its global compound growth rate (CAGR) estimated to reach 8.5% between 2018-2023, outstripping traditional new chemical entity sectors. Emerging novel drugs show ...
Sep. 23, 2018
TopicsProductionPharma & Biotech Processing
M&A in Pharma and CRO/CMO Industry
Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself. The recent acquisitions of Capsugel by Lonza and of ...
Sep. 22, 2018
TopicsProductionPharma & Biotech Processing
Innovative Anti-Infectives
Natural products have been used since thousands of years for the treatment of a wide range of medical conditions in the form of traditional medicines. Today 60% of all new small molecule drugs are still derived from nature, and natural ...
Sep. 22, 2018
TopicsProductionPharma & Biotech Processing
Managing Highly Challenging GMP Processes
The German service provider Pitzek GMP Consulting, based in Neustadt/Weinstraße, has nearly 30 years of consultancy experience in GMP processing for pharmaceutical and life science product. In Germany, a team of almost 30 experts in ...
Sep. 21, 2018
TopicsProductionPharma & Biotech Processing
Digital Transformation
The pharmaceutical industry has gone through two decades of rapid technological innovations. These include combinatorial chemistry, recombinant DNA technology, development of knockout animal models & high throughput screening, and ...
Sep. 21, 2018
TopicsProductionPharma & Biotech Processing
A Wide Spectrum of Contract Services
With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service models that provide both active pharmaceutical ingredient ...
Sep. 20, 2018
TopicsProductionPharma & Biotech Processing
Winning Strategies in the Pharmaceutical CDMO Industry
Despite the favorable economic environment, the global economic risk factors have intensified against the background of record global debt and a rise in geopolitical risk. Amid growing uncertainty and regionalization, values such as trust, ...
Sep. 19, 2018
TopicsEconomy & Business
Supply Security of Non-cGMP Materials
The topic of supply chain security is not a new one for the pharmaceutical industry, and much of that discussion has been dominated by the cGMP portion of the API supply chain. The discussion regularly addresses reduction of risk, superior ...

12 3 4 5 6 7 8…

Register now!

The latest information directly via newsletter.

GIT Verlag